New Delhi, May 27 -- Brokerage firm Choice Broking, in its recent report, said that it expects around 20% upside in the healthcare stock Park Medi World, while maintaining a 'buy' rating with a revised target price of Rs.350 apiece.

The brokerage firm further said that the management expects Park Hospitals' growth to be driven by aggressive capacity expansion, with efficient capital deployment, a richer case mix, optimised ALOS, improved payor mix and revised CGHS rate benefits.

The management, in an interview with the brokerage firm, revealed that by the second year, revenues are expected to scale up to Rs.1,400 million (40% YoY growth), with EBITDA improving to Rs.35 million (25% margin) and PAT of Rs.21 million (15% margin), supporte...